Skip to main content
Clinical Trials/NCT03357146
NCT03357146
Completed
Not Applicable

Optical Coherence Tomography Angiography Examinations in Chronic Retinal Artery Occlusion

Semmelweis University1 site in 1 country42 target enrollmentJanuary 9, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Retinal Artery Occlusion
Sponsor
Semmelweis University
Enrollment
42
Locations
1
Primary Endpoint
Capillary density in relation to healthy subjects
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

Purpose of the study is to examine the retinal blood flow in chronic cases of retinal artery occlusion with non-invasive, non-contact optical coherence tomography angiography.

Detailed Description

Occlusion of the retinal arteries is an emergency which causes sudden, painless unilateral vision loss. Loss of blood flow causes ischemic damage to the retina. The extent of damage depends on the area affected. Following the acute phase of the disease re-canalization occurs and lesser blood flow can be detected usually without functional recovery. Purpose of the study is to examine the retinal blood flow in chronic cases of retinal artery occlusion. Standard procedures to examine this disease include retinoscopy following pupil dilation, fluorescein angiography and more recently, optical coherence tomography (OCT). The latest direction in OCT development was OCT angiography (OCTA) which is a software upgrade that allows detection of blood flow based on motion contrast. Similar to previous OCT machines OCTA is also non-invasive and non-contact and does not require any intravenous agents. OCT machines are approved in the EU and the US and are not experimental devices. The device used in this study is the commercially available Zeiss Cirrus HD OCT Angioplex 5000 that operates with spectral-domain technology.

Registry
clinicaltrials.gov
Start Date
January 9, 2017
End Date
August 30, 2021
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Miklos Schneider MD, PhD

Assistant Professor

Semmelweis University

Eligibility Criteria

Inclusion Criteria

  • central or branch retinal artery occlusion
  • at least 6 months of onset
  • signed informed consent

Exclusion Criteria

  • known epilepsy
  • incapacity
  • presence of optical media opacities that would disturb the imaging
  • presence of other retinal diseases that would disturb the evaluation of images

Outcomes

Primary Outcomes

Capillary density in relation to healthy subjects

Time Frame: Through study completion, 1 year

Secondary Outcomes

  • Correlation of capillary density and retinal thickness(Through study completion, 1 year)

Study Sites (1)

Loading locations...

Similar Trials